NIH-funded research R15 grant

Using light to control platinum compounds for medical applications

Official title: Light-Controlled Supramolecular Platinum Complexes for Biomedical Applications

Funded at Kent State University · NIH-10796064 · Data updated 2026-11-12

This study is exploring a new way to use special light to help activate certain medicines that contain platinum, aiming to make treatments more effective and with fewer side effects for patients.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionKent State University
NIH-funded
Lab location1 site (Kent, United States)
Project startApril 1, 2024
Project endMarch 31, 2027
Funding year2024
Award (this year)$434,148
NIH project number1R15GM152919-01
Project IDNIH-10796064 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include patients with cancers that are currently treated with platinum-based chemotherapy.

Less likely to help

Patients who do not have cancer or those whose cancers are not responsive to platinum-based therapies may not benefit from this research.

What this research studies

This research investigates a novel method of using near-infrared (NIR) light to activate platinum-based compounds that can be used in medical treatments. By employing a technique called photo-uncaging, the researchers aim to control the release of bioactive substances in a precise manner, allowing for targeted therapy. The study focuses on developing new platinum complexes that can be activated by NIR light, which penetrates deeper into tissues compared to traditional UV light. This approach could enhance the effectiveness of treatments while minimizing side effects.

Why it matters

Potential benefit: If successful, this research could lead to more effective and targeted cancer therapies with fewer side effects.

How similar studies have gone: While the use of light for drug activation is a growing field, this specific approach using NIR light with platinum complexes is relatively novel and has not been extensively tested.

Where this research is happening

  • Kent State University
    Kent, United States
    Active

Researchers

  • Principal investigator: Zheng, Yaorong — Kent State University
  • Study coordinator: Zheng, Yaorong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.